By Brian M. Reiser Gilead Sciences stock (Nasdaq: Gild) popped in after hours trading on the strength of some good coronavirus news. The stock popped about 13%. The price increase was based on reports of a possible effective drug therapy for COVID-19.
The news came in the form of a video reported by STAT news. The video outlines a clinical study in which sick participants have responded positively to the drug remdesivir. The question is, how will this affect Gilead Sciences stock in the coming days?
A Potential COVID-19 Treatment?
The clinical study reported by STAT News involves 150 patients sick from the coronavirus. All of these …read more
